Corante

About this author
Zack Lynch Zack Lynch is the executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT,Center for Cognitive Liberty & Ethics, the Center for Neuroeconomic Studies and SocialText, a social software company. He is currently writing a book on how neurotech is shaping business, politics and culture. Please send newsworthy items or feedback - to Zack Lynch.
Receive by email

GUEST AUTHOR ARCHIVES
Just Released the 2008 Tribalization of Business study - an in-depth look at how 140+ organizations are managing and measuring online communities

Brain Waves

« A Scary Illusion - Mr. Angry and Ms. Calm | Main | Neurosocieties: the rise and impact of the new brain sciences »

November 2, 2007

NIO Unveils Top 10 Neuroscience Trends of 2007

Email This Entry

Posted by Zack Lynch

Topten.jpgThe Neurotechnology Industry Organization developed this “top ten” list of emerging areas of neuroscience that will impact the future of treatments for brain and nervous system in anticipation of cutting edge research being presented at The Society for Neuroscience Conference being held in San Diego, California, November 3-7. NIO will be hosting a booth (#4311) and neurotech industry partnering social at the conference. Stop by for a visit.

Top 10 Trends of 2007:
1. Advancing discovery tools underpin innovation: Beyond biochips and brain imaging, recent advances in neuroinformatics, image-based neural circuit analysis, and neural computation are accelerating the pace of neuroscientific discovery beyond what was imagined a decade ago.
2. Neuroimmunology leading to new treatment targets: The discovery that immune molecules play a crucial role in shaping neuronal connections opens up new treatment targets for Alzheimer’s, autism, ALS, Parkinson’s, schizophrenia, and nerve injury.
3. National Neurotechnology Initiative - Momentum for the new $200M/year federal R&D initiative aimed at accelerating translational neurotech innovation and improving the effectiveness of FDA review process for neuroscience drugs, devices and diagnostics grows.
4. Neurodevice interfaces improve prosthetics and treatments - Advanced brain-machine interfaces (BMI) enable the severely handicapped to independently compose e-mails and operate a TV in their homes. Other neurodevices provide functional stimulation for the treatment of pain, Parkinson’s, obesity, and psychiatric disorders.
5. Addiction advances: New research clarifies the role of drugs on sleep, cocaine’s potency, and the brain changes that occur due to abuse leading to new treatment strategies for this epidemic impacting over 1.1 billion worldwide.
6. Normal aging brain gets more attention: More research and development is being focused on thinking impairments that only partially limit independence and quality of life for senior citizens, adults and school aged children. Neurosoftware will penetrate nursing homes and schools, as brain fitness software becomes new first-line treatment strategy.
7. Regenerating the spinal cord: New experimental therapies in development could open the doors for research to improve treatments for people with spinal cord injuries, brain injuries, stroke, and other severe movement disorders
8. Prevention evidence grows: You are what you eat; smoking is as bad as we thought; and new studies reveal the effects of environmental substances on Alzheimer’s disease, Parkinson’s disease and others.
9. Emotional disorders research advances: New research continues to link neurogenesis to treatment of depression. A better understanding of PTSD should lead to new treatment regimes.
10. Neuroscience infiltrates society: From neuroeconomics to neuroesthetics to neuroethics and neurolaw, the influence of neuroscience on society continues to grow.

Advances across a wide spectrum of neuroscience research are making possible the development of more effective treatments for the nearly 100 million Americans and 2 billion people worldwide that currently suffer from brain-related illnesses.

Comments (0) + TrackBacks (0) | Category: Neurotech Industry


POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)





Remember me?


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
European Neurosociety Developments
NIO bets big in capital
Many Faces of a Face - Neuroesthetics
NERV vs. NBI vs. NASDAQ
Brain Doping on the Rise in Poker, School and Symphony
NIO Year in Review and Look Forward to 2008
Neurorealism Rising
Do Your Worst